IGM Biosciences A/S — Form D
IGM Biosciences A/S of KONGENS LYNGBY, G7, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-16. The offering totals $2.4M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-01-16
- Form: D
- Accession: 0001727622-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.4M
- Amount sold: $2.1M
- Remaining: $222K
- Minimum investment: $1K
- Investors: 11
- Date of first sale: 2017-12-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-303330
Issuer
- Name: IGM Biosciences A/S
- CIK: 0001727622
- Entity type: Corporation
- Jurisdiction: DENMARK
- Incorporated: 2017
- Address: HALDOR TOPSOES ALLE 1, KONGENS LYNGBY, G7, 2800
- Phone: 45 5339 3404
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Christina Haldor Topsoe | Director | Kongens Lyngby, G7 |
| Henrik Haldor Topsoe | Director | Kongens Lyngby, G7 |
| Jakob Haldor Topsoe | Director | Mountain View, CA |
| Hans Kornerup | Executive Officer | Kongens Lyngby, G7 |
More